HomeWorld NewsUS NewsCancer drug company Tesaro shares rise 39% following report that it will...

Cancer drug company Tesaro shares rise 39% following report that it will explore sale

Cancer drug company Tesaro shares rise 39% following report that it will explore sale

Tesaro shares soared 39 percent Friday upon a Bloomberg report that the pharmaceutical company will explore the opportunity of a sale.

This comes exactly one week after the cancer drug company fell more than 20 percent during after-hours trading after the release of drug trial results for treatment of small cell lung cancer. A spokesperson declined to comment.

Tesaro also explored a sale in May 2017, but it did not come to a close. Shares then fell more than 11 percent during that time.




More Related Articles

Sign up to receive awesome contents in your inbox, everyday in the morning.

We don’t spam! Read our privacy policy for more info.

LEAVE A REPLY

Please enter your comment!
Please enter your name here

We use cookies to ensure that we give you the best experience on our website.